• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型非肽类血管加压素拮抗剂对大鼠进行性肾硬化的影响。

Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.

作者信息

Okada H, Suzuki H, Kanno Y, Saruta T

机构信息

Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

出版信息

J Cardiovasc Pharmacol. 1995 May;25(5):847-52. doi: 10.1097/00005344-199505000-00023.

DOI:10.1097/00005344-199505000-00023
PMID:7630164
Abstract

Effects of novel, nonpeptide vasopressin V1 and V2 receptor antagonists on partially nephrectomized and salt-loaded spontaneously hypertensive rats (SHR), which develop severe hypertension and progressive nephrosclerosis, were investigated. SHR were 5/6-nephrectomized and fed a high salt diet. The rats were divided into four groups: group 1 was an untreated control, group 2 received the V1 antagonist OPC-21268, group 3 received the V2 antagonist OPC-31260, and group 4 received both the V1 and V2 antagonists. The V1 antagonist alone or combined with the V2 antagonist significantly decreased the increase in blood pressure (BP) of groups 2 and 4 rats, but the V2 antagonist alone did not reduce the increase in BP of the group 3 rats. The V2 antagonist alone or combined with the V1 antagonist induced a significant diuresis of rats in groups 3 and 4. The increase in urinary protein excretion and the progression of renal hyaline arteriolosclerosis were attenuated by the V1 antagonist with or without the V2 antagonist in rats in groups 2 and 4, but not by the V2 antagonist alone in rats in group 3. This implies that the progressive nephrosclerosis in SHR with partial renoablation and salt-loading was associated with V1 agonism.

摘要

研究了新型非肽类血管加压素V1和V2受体拮抗剂对部分肾切除并高盐喂养的自发性高血压大鼠(SHR)的影响,这类大鼠会发展为严重高血压和进行性肾硬化。对SHR进行5/6肾切除并给予高盐饮食。将大鼠分为四组:第1组为未治疗的对照组,第2组给予V1拮抗剂OPC - 21268,第3组给予V2拮抗剂OPC - 31260,第4组给予V1和V2拮抗剂。单独使用V1拮抗剂或与V2拮抗剂联合使用均显著降低了第2组和第4组大鼠的血压升高,但单独使用V2拮抗剂并未降低第3组大鼠的血压升高。单独使用V2拮抗剂或与V1拮抗剂联合使用均使第3组和第4组大鼠产生显著利尿作用。第2组和第4组大鼠单独使用V1拮抗剂或与V2拮抗剂联合使用均可减轻尿蛋白排泄增加和肾透明小动脉硬化的进展,但第3组大鼠单独使用V2拮抗剂则无此作用。这表明部分肾切除并高盐喂养的SHR中的进行性肾硬化与V1激动作用有关。

相似文献

1
Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.新型非肽类血管加压素拮抗剂对大鼠进行性肾硬化的影响。
J Cardiovasc Pharmacol. 1995 May;25(5):847-52. doi: 10.1097/00005344-199505000-00023.
2
Chronic and selective vasopressin blockade in spontaneously hypertensive rats.
Am J Physiol. 1994 Dec;267(6 Pt 2):R1467-71. doi: 10.1152/ajpregu.1994.267.6.R1467.
3
Effects of nonpeptide and selective V1 and V2 antagonists on blood pressure short-term variability in spontaneously hypertensive rats.非肽类及选择性V1和V2拮抗剂对自发性高血压大鼠血压短期变异性的影响。
J Pharmacol Sci. 2004 May;95(1):47-55. doi: 10.1254/jphs.95.47.
4
Effects of vasopressin V1 and V2 receptor antagonists on the development of salt-induced hypertension in Dahl rats.
J Cardiovasc Pharmacol. 1995 Oct;26(4):548-54. doi: 10.1097/00005344-199510000-00007.
5
Effect of a nonpeptide vasopressin V1 antagonist (OPC-21268) on experimental accelerated focal glomerulosclerosis.非肽类血管加压素V1拮抗剂(OPC-21268)对实验性加速性局灶节段性肾小球硬化的影响
Nephron. 1996;73(4):629-36. doi: 10.1159/000189151.
6
Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats.非肽类血管加压素受体拮抗剂对大鼠发育性及已形成的去氧皮质酮盐性高血压的影响。
Clin Exp Hypertens. 1995 Apr;17(3):469-83. doi: 10.3109/10641969509037419.
7
Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats.血管加压素V1和V2受体拮抗剂对大鼠进行性肾衰竭的影响。
Clin Sci (Lond). 1994 Apr;86(4):399-404. doi: 10.1042/cs0860399.
8
Vasopressin V2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive rats.血管加压素V2受体增强清醒自发性高血压大鼠压力反射的增益。
Am J Physiol. 1999 Mar;276(3):R872-9. doi: 10.1152/ajpregu.1999.276.3.R872.
9
Organic osmolytes in rat renal inner medulla are modulated by vasopressin V1 and/or V2 antagonists.大鼠肾内髓质中的有机渗透质受血管升压素V1和/或V2拮抗剂调节。
Am J Physiol. 1994 Jul;267(1 Pt 2):F146-52. doi: 10.1152/ajprenal.1994.267.1.F146.
10
Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats.血管加压素V1受体拮抗剂OPC-21268对自发性高血压大鼠肾小球生长因子表达的影响。
Regul Pept. 1997 Oct 31;72(2-3):87-95. doi: 10.1016/s0167-0115(97)01041-0.

引用本文的文献

1
G-Protein-Coupled Receptors in Chronic Kidney Disease Induced by Hypertension and Diabetes.高血压和糖尿病所致慢性肾脏病中的G蛋白偶联受体
Cells. 2025 May 16;14(10):729. doi: 10.3390/cells14100729.
2
Vasopressin Increases Urinary Acidification V1a Receptors in Collecting Duct Intercalated Cells.加压素增加集合管闰细胞中的尿酸化 V1a 受体。
J Am Soc Nephrol. 2019 Jun;30(6):946-961. doi: 10.1681/ASN.2018080816. Epub 2019 May 16.
3
Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy.
慢性肾脏病对肾切除大鼠肾脏皮质血管加压素系统表达变化的影响。
Biomed Res Int. 2018 Jun 14;2018:2607928. doi: 10.1155/2018/2607928. eCollection 2018.
4
Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor.血管加压素通过诱导血管内皮生长因子的自分泌来调节大鼠系膜细胞的生长。
J Physiol Sci. 2011 Mar;61(2):115-22. doi: 10.1007/s12576-010-0128-5. Epub 2011 Jan 13.